Pharmacovigilance is all activities regarding detection, assessment, understanding, and prevention of side effects or other problems related to drug use. The pharmaceutical industry is required to implement pharmacovigilance in accordance with Regulation of BPOM No 15 - 2022
Pharmacovigilance carries out monitoring and reporting which includes
1. Drug safety aspects in the context of detection, assessment, understanding, prevention of side effects or other problems related to use
2. Changes in drug benefit-risk profile; and / or
3. Quality aspects that affect drug safety.
As a form of implementation of the application of pharmacovigilance, PT Kimia Farma Tbk made a container to receive complaints about products that are produced, distributed and marketed by PT Kimia Farma. This is a form of concern and seriousness of PT Kimia Farma Tbk to improve and maintain the safety, efficacy, and quality of a product.
If you have a product complaint related to either Product Quality or an unwanted drug reaction, contact us by opening the link below:
